Global Head Lice Infestation Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Head Lice Infestation Drug market size was valued at US$ 420 million in 2024 and is forecast to a readjusted size of USD 523 million by 2031 with a CAGR of 3.2% during review period.

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.

Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.

This report is a detailed and comprehensive analysis for global Head Lice Infestation Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Head Lice Infestation Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031

Global Head Lice Infestation Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031

Global Head Lice Infestation Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031

Global Head Lice Infestation Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Head Lice Infestation Drug

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Head Lice Infestation Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Omega Pharma, Thornton and Ross, Prestige Brands, Perrigo, Actavis, Reckitt Benckier, Tyratech, Shionogi, TecLabs, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Head Lice Infestation Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Lotion
Creams
Shampoo
Other

Market segment by Application
Children
Adult

Major players covered
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Head Lice Infestation Drug product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Head Lice Infestation Drug, with price, sales quantity, revenue, and global market share of Head Lice Infestation Drug from 2020 to 2025.

Chapter 3, the Head Lice Infestation Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Head Lice Infestation Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Head Lice Infestation Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Head Lice Infestation Drug.

Chapter 14 and 15, to describe Head Lice Infestation Drug sales channel, distributors, customers, research findings and conclusion.